Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-002708
Filing Date
2019-02-05
Accepted
2019-02-05 19:52:27
Documents
1
Period of Report
2019-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3712
  Complete submission text file 0000899243-19-002708.txt   5362
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Issuer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O HEDGEPATH PHARMACEUTICALS, INC. 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address
MAGRAB E. BRENDAN (Reporting) CIK: 0001196062 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13467 | Film No.: 19569559